pharmanews

Treatment approved for hospitalized COVID-19 patients; Update on Varenicline supply; Limits have been set for the Janssen COVID-19 vaccine; Safety alert issued for a COVID-19 test; And certain hemodialysis machines may carry the potential for chemical exposure.

In this episode, GOLD talks to Wayne Best, Chief Creative Officer, VMLY&R, who offers his insights on the innovative ‘I Will Always Be Me’ project with the MND Association – a fascinating and important cause with so much potential to inspire the pharma industry. But that’s not all! Join us to delve into the latest GOLD infographic on supply chain stability and hear the latest industry news you might have missed.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Risks to supply chain vulnerability – infographic https://www.emg-gold.com/_files/ugd/b8a9db_2fee0c32ea6940e69a36e4d939eedade.pdf
• Reacting to supply chain risks https://www.emg-gold.com/post/reacting-to-supply-chain-risks
• AI and Big Data at the forefront of pharma in 2022 https://www.emg-gold.com/post/ai-and-big-data-at-the-forefront-of-pharma-in-2022
• The latest GOLD issue, including the blockchain feature mentioned https://go.emg-gold.com/gold-20-access-form

The latest status on the Janssen vaccine; Updated guidance from the National Institutes of Health on COVID-19 antibody treatments; The FDA changes in-person mifepristone dispensing; Xolair prefilled syringe approved for self-administration in select patients; And the AI world comes to colonoscopies.